
### [MONDO:0020107](http://purl.obolibrary.org/obo/MONDO_0020107)
**Label:** hemolytic anemia due to an erythrocyte nucleotide metabolism disorder

**Subclasses:** [MONDO:0012967](http://purl.obolibrary.org/obo/MONDO_0012967) (hemolytic anemia due to adenylate kinase deficiency), [MONDO:0020458](http://purl.obolibrary.org/obo/MONDO_0020458) (hemolytic anemia due to erythrocyte adenosine deaminase overproduction), [MONDO:0009946](http://purl.obolibrary.org/obo/MONDO_0009946) (hemolytic anemia due to pyrimidine 5' nucleotidase deficiency), 

**Mapped go classes:** [GO:0009117](http://purl.obolibrary.org/obo/GO_0009117) (nucleotide metabolic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004017](http://purl.obolibrary.org/obo/GO_0004017) (adenylate kinase activity), [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0019205](http://purl.obolibrary.org/obo/GO_0019205) (nucleobase-containing compound kinase activity), [GO:0016776](http://purl.obolibrary.org/obo/GO_0016776) (phosphotransferase activity, phosphate group as acceptor), [GO:0008253](http://purl.obolibrary.org/obo/GO_0008253) (5'-nucleotidase activity), [GO:0006172](http://purl.obolibrary.org/obo/GO_0006172) (ADP biosynthetic process), [GO:0009142](http://purl.obolibrary.org/obo/GO_0009142) (nucleoside triphosphate biosynthetic process), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0004550](http://purl.obolibrary.org/obo/GO_0004550) (nucleoside diphosphate kinase activity), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0046033](http://purl.obolibrary.org/obo/GO_0046033) (AMP metabolic process), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0016776](http://purl.obolibrary.org/obo/GO_0016776) (phosphotransferase activity, phosphate group as acceptor) and [GO:0019205](http://purl.obolibrary.org/obo/GO_0019205) (nucleobase-containing compound kinase activity) 60.82%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 60.00%
- [GO:0004550](http://purl.obolibrary.org/obo/GO_0004550) (nucleoside diphosphate kinase activity) 60.00%
- [GO:0004017](http://purl.obolibrary.org/obo/GO_0004017) (adenylate kinase activity) 60.00%
- [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding) 60.00%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%


